PRINCETON, N.J., June 3 /PRNewswire/ -- Celator Pharmaceuticals reported positive results from its CPX-1 Phase 2 clinical trial in patients with advanced colorectal cancer. CPX-1 is a liposomal ...
PRINCETON, N.J., Nov. 18 /PRNewswire/ -- Celator Pharmaceuticals today announced that the first patient has been treated in a randomized Phase 2 clinical study of CPX-351 (Cytarabine:Daunorubicin) ...
Capital Power Corporation SUBSC RCPTS (CPX.R:CA) latest earnings report: revenue, EPS, surprise, history, news and analysis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results